| Haber: |
Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: Congress may miss deadline to pass FDA user-fee bill; ViiV is urged to lower price for its HIV prevention drug
With just over two month to go, it appears increasingly likely that Congress is going to miss its deadlines to pass a final FDA appropriations bill and a user-fee reauthorization.
https://www.statnews.com/pharmalot/2022/07/22/covid19-vaccine-monkeypox-fda-hiv-cvs-abortion/?utm_campaign=rss
|
